SETI Hub Wiki - User contributions [en]

Fluoxetine: A Comprehensive Overview Of A Selective Serotonin Reuptake Inhibitor

2026-07-16T19:16:49Z

AnitaHolder5: Created page with " Fluoxetine, commonly known by the brand name Prozac, is a first-line antidepressant belonging to the class of selective serotonin reuptake inhibitors (SSRIs). Approved by the U.S. Food and Drug Administration (FDA) in 1987, fluoxetine revolutionized the treatment of depression and other psychiatric disorders due to its favorable side effect profile compared to tricyclic antidepressants and monoamine oxidase inhibitors. This report provides a concise overview of fluox..."

Fluoxetine, commonly known by the brand name Prozac, is a first-line antidepressant belonging to the class of selective serotonin reuptake inhibitors (SSRIs). Approved by the U.S. Food and Drug Administration (FDA) in 1987, fluoxetine revolutionized the treatment of depression and other psychiatric disorders due to its favorable side effect profile compared to tricyclic antidepressants and monoamine oxidase inhibitors. This report provides a concise overview of fluoxetine’s pharmacology, clinical indications, efficacy, adverse effects, and key considerations in clinical practice. Pharmacology and Mechanism of Action Fluoxetine is a potent and highly selective inhibitor of the serotonin transporter (SERT), located on the presynaptic neuron. By blocking the reuptake of serotonin (5-hydroxytryptamine, 5-HT) from the synaptic cleft, fluoxetine increases the availability of serotonin for postsynaptic receptor binding. This enhancement of serotonergic neurotransmission is believed to underlie its antidepressant and Posts - [https://beautyandcolours.it/posts/ https://beautyandcolours.it/posts/] - anxiolytic effects. Unlike older antidepressants, fluoxetine has minimal affinity for histaminergic, cholinergic, or adrenergic receptors, reducing the incidence of sedation, anticholinergic effects, and orthostatic hypotension. The drug is absorbed orally with a bioavailability of about 72%. It is extensively metabolized in the liver via the [https://www.travelwitheaseblog.com/?s=cytochrome cytochrome] P450 enzyme CYP2D6 and, to a lesser extent, CYP2C9 and CYP3A4, producing the active metabolite norfluoxetine, which has a half-life of 4–16 days. The long half-life of fluoxetine (1–4 days) and norfluoxetine (7–15 days) allows for once-daily dosing and provides a gradual withdrawal profile, but also increases the risk of drug interactions and prolongs the time to steady-state concentration (approximately 4–5 weeks). Clinical Indications Fluoxetine is approved for a range of psychiatric conditions in adults and children. Its primary indication is major depressive disorder (MDD), where it is effective in reducing depressive symptoms and preventing relapse. It is also widely used for obsessive-compulsive disorder (OCD) in adults and children aged 7 and older, bulimia nervosa (moderate to severe), and panic disorder with or without agoraphobia. Off-label uses include social anxiety disorder, premenstrual dysphoric disorder (PMDD), post-traumatic stress disorder (PTSD), and premature ejaculation. In addition, fluoxetine is used in combination with olanzapine (Symbyax) for treatment-resistant depression and bipolar depression. Efficacy Numerous randomized controlled trials and meta-analyses have established fluoxetine’s efficacy in acute and maintenance treatment of MDD. Response rates are approximately 50–60%, with remission rates around 30–40% after 8–12 weeks, comparable to other SSRIs. In OCD, fluoxetine reduces symptom severity by 20–40% on the Yale-Brown Obsessive Compulsive Scale. For bulimia nervosa, it decreases binge-eating and vomiting episodes. However, its onset of therapeutic action typically takes 2–4 weeks, and maximal benefit may require 6–8 weeks. Adverse Effects The side effect profile of fluoxetine is generally milder than that of older antidepressants, but still notable. Common adverse effects include gastrointestinal disturbances (nausea, diarrhea, loss of appetite), insomnia, nervousness, fatigue, headache, and sexual dysfunction (decreased libido, delayed ejaculation, anorgasmia). Weight gain is less pronounced than with other SSRIs like paroxetine, but long-term use may cause modest weight increase. Less common but more serious risks include serotonin syndrome (especially when combined with other serotonergic agents), bleeding disorders due to impaired platelet aggregation, hyponatremia (particularly in elderly or volume-depleted patients), and acute angle-closure glaucoma. In children and adolescents, fluoxetine carries a black-box warning for increased risk of suicidal ideation and behavior during initial treatment; close monitoring is essential. Drug Interactions Fluoxetine’s inhibition of CYP2D6 can significantly increase plasma levels of drugs metabolized by this enzyme, such as tricyclic antidepressants, antipsychotics (e.g., haloperidol, risperidone), beta-blockers (metoprolol), and antiarrhythmics (flecainide, propafenone). Co-administration with monoamine oxidase inhibitors (MAOIs) is contraindicated due to risk of severe serotonin syndrome; a washout period of at least 5 weeks is recommended after stopping fluoxetine before starting an MAOI. Similarly, combination with other SSRIs, SNRIs, triptans, or St. John’s wort requires caution. Special Populations In pregnancy, fluoxetine is categorized as FDA Pregnancy Category C (now replaced by more nuanced labeling). [https://Pinterest.com/search/pins/?q=Studies Studies] have shown a small increased risk of persistent pulmonary hypertension in the newborn and subtle neurobehavioral effects; however, untreated maternal depression poses its own risks. The drug is excreted in breast milk, but levels are low, and most guidelines consider it acceptable during breastfeeding with monitoring. For elderly patients, lower starting doses (e.g., 10 mg/day) are recommended due to increased sensitivity and risk of hyponatremia. Renal or hepatic impairment may reduce clearance, necessitating dose adjustment. Withdrawal and Discontinuation Because of the long half-life of fluoxetine and its active metabolite, withdrawal symptoms are less common and less severe than with shorter-acting SSRIs like paroxetine or venlafaxine. Nevertheless, abrupt discontinuation can cause dizziness, paresthesias, irritability, anxiety, and flu-like symptoms. Tapering over several weeks is advised. Conclusion Fluoxetine remains a cornerstone in the pharmacotherapy of major depressive disorder and other serotonergic-related conditions. Its favorable side effect profile, once-daily dosing, and long half-life offer advantages for adherence and withdrawal management, though potential for drug interactions and slow onset require careful clinical judgment. Continued research on personalized medicine may optimize its use based on genetic polymorphisms affecting metabolism. Overall, fluoxetine’s efficacy and safety record over three decades make it a valuable tool in psychiatric treatment, balancing benefits against risks in diverse patient populations.

Alesse: A Comprehensive Overview Of The Combined Oral Contraceptive

2026-07-16T18:49:00Z

AnitaHolder5: Created page with " Alesse is a widely prescribed combined oral contraceptive (COC) pill used primarily for the prevention of pregnancy. It contains two synthetic hormones: ethinyl estradiol, an estrogen, and levonorgestrel, a progestin. Each active tablet delivers a low dose of 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel. This formulation places Alesse in the category of low-dose oral contraceptives, designed to minimize estrogen-related side effects while m..."

Alesse is a widely prescribed combined oral contraceptive (COC) pill used primarily for the prevention of pregnancy. It contains two synthetic hormones: ethinyl estradiol, an estrogen, and levonorgestrel, a progestin. Each active tablet delivers a low dose of 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel. This formulation places Alesse in the category of low-dose oral contraceptives, designed to minimize estrogen-related side effects while maintaining high contraceptive efficacy. Available in a 21-day regimen (21 active pills followed by 7 placebo pills) or a 91-day extended-cycle version (Alesse-28), it offers flexibility for users. This report examines Alesse’s mechanism of action, clinical efficacy, safety profile, common side effects, risks, benefits, and practical considerations, providing a balanced view for healthcare providers and patients. Mechanism of Action Alesse prevents pregnancy through multiple pathways. The primary mechanism is suppression of ovulation via negative feedback on the hypothalamic-pituitary-ovarian axis. Ethinyl estradiol inhibits the secretion of follicle-stimulating hormone (FSH), preventing follicular development, while levonorgestrel suppresses the luteinizing hormone (LH) surge necessary for ovulation. Additionally, the progestin thickens cervical mucus, creating a barrier that impedes sperm penetration. It also alters endometrial lining, reducing the likelihood of implantation should fertilization occur. The combined effect provides a robust contraceptive barrier. Efficacy When used correctly and consistently, Alesse has a perfect-use failure rate of less than 1% per year (0.3% typically). However, typical-use failure rates range from 5-9% due to missed pills, vomiting, diarrhea, or drug interactions. Compared to other COCs, Alesse’s low dose does not compromise efficacy; it remains highly reliable. The 7-day placebo interval maintains cycle control and withdrawal bleeding, though some users experience breakthrough bleeding, especially in the initial months. Dosage and Administration Alesse is usually initiated on the first day of menstruation (Day 1 start) for immediate contraceptive protection. Alternatively, a Sunday start may be used, requiring backup contraception for the first 7 days. Each pack contains 21 active pills taken daily at approximately the same time. After the last active pill, a 7-day hormone-free interval follows, during which withdrawal bleeding occurs. The 28-day pack includes 7 placebo pills to maintain daily dosing habit. For extended-cycle use, 84-day regimens are available under different brand names (e.g., Seasonale) but Alesse itself is primarily 21/7. Missed pills require specific instructions: one late pill (up to 24 hours) can be taken as soon as remembered; two or more missed pills may necessitate backup contraception and emergency contraception if unprotected intercourse occurred. Benefits Beyond Contraception Alesse offers several non-contraceptive health benefits. It regulates menstrual cycles, reduces heavy bleeding (menorrhagia), and decreases dysmenorrhea (painful periods). Users often experience fewer and lighter periods, lower incidence of iron-deficiency anemia, and reduced symptoms of premenstrual syndrome (PMS). Acne improvement is common due to the anti-androgenic effect of levonorgestrel (though some progestins may worsen acne). Long-term use is associated with reduced risk of ovarian and endometrial cancers, as well as decreased incidence of benign breast disease and ovarian cysts. However, these benefits must be weighed against potential risks. Side Effects Common side effects include nausea, breast tenderness, headache, weight changes (mostly fluid retention), mood swings, and spotting or breakthrough bleeding. Most of these are mild and often resolve within 2-3 cycles. Nausea may be minimized by taking the pill with food or at bedtime. Serious side effects are rare but include venous thromboembolism (VTE), myocardial infarction, stroke, and hepatic adenomas. The risk of VTE is increased in users of COCs, especially those with additional risk factors such as smoking (particularly over age 35), obesity, Accupril 10mg prezzo corretto €0.61 �� — Hypertension ([https://simup.it/ simup.it]), or personal/family history of thrombosis. Alesse’s low estrogen dose reduces but does not eliminate this risk. Risks and Contraindications Absolute contraindications include current or history of VTE, known thrombogenic mutations (e.g., Factor V Leiden), active liver disease, estrogen-dependent neoplasia (e.g., breast cancer), undiagnosed abnormal uterine bleeding, and pregnancy. Relative contraindications: smoking >15 cigarettes/day in women over 35, uncontrolled hypertension (systolic >160), migraine with aura (especially after age 35), diabetes with vasculopathy, and prolonged immobilization. The World Health Organization provides eligibility criteria categorizing conditions as no restriction, benefits outweigh risks, risks outweigh benefits, or unacceptable. Alesse should be used [https://imgur.com/hot?q=cautiously cautiously] in women with gallbladder disease or depression. Drug Interactions Certain medications can reduce Alesse’s efficacy by inducing hepatic enzyme activity (CYP3A4) or interfering with enterohepatic recirculation. Strong inducers include rifampin, rifabutin, barbiturates, carbamazepine, phenytoin, primidone, and St. John’s wort. Moderate inducers like topiramate and oxcarbazepine may also reduce efficacy. Antibiotics not known to induce enzymes (e.g., penicillins, tetracyclines) are now considered low risk, but backup contraception is still recommended for the duration of antibiotic use plus 7 days. Antifungals (griseofulvin), HIV protease inhibitors, and some antiepileptics may also interact. Conversely, Alesse can affect the metabolism of other drugs, such as cyclosporine, theophylline, and lamotrigine, potentially altering their levels. Special Populations Adolescents: Alesse is safe for post-menarchal adolescents, but education on adherence and side effects is crucial. Bone mineral density is not adversely affected with low-dose COCs. Perimenopausal women: May be used until menopause, but base risk of cardiovascular events and smoking should be assessed. Postpartum: Generally avoided for the first 21 days due to increased thromboembolic risk, especially in breastfeeding women (estrogen may reduce milk supply). Progestin-only methods are preferred. Women with obesity: Efficacy may be slightly reduced, but Alesse remains effective. Breakthrough bleeding may be more common. Risk of VTE increases with BMI >30, especially with concurrent estrogen use. Patient Counseling Points Healthcare providers should emphasize: Take one pill daily at the same time. If a pill is missed, refer to package insert or prescribing information for corrective steps. Use backup contraception during initiation (first 7 days if Sunday start) or if pills are missed. Report symptoms of VTE: unilateral leg swelling, chest pain, shortness of breath. Annual blood pressure monitoring is recommended. Smoking cessation is strongly advised in women over 35. Conclusion Alesse is a well-established, low-dose combined oral contraceptive offering high efficacy, menstrual regulation, and non-contraceptive benefits. Its safety profile is favorable for healthy, non-smoking women up to age 35, with caution beyond that. Like all COCs, it carries a small but serious risk of thromboembolism. Proper patient selection, counseling, and follow-up are essential to maximize benefits and [https://data.gov.uk/data/search?q=minimize minimize] harms. Alesse remains a cornerstone in modern family planning, providing reliable contraception while empowering women to manage reproductive health.

User:AnitaHolder5

2026-07-16T18:48:52Z

AnitaHolder5: Created page with "My name's Senaida Purves but everybody calls me Senaida. I'm from Denmark. I'm studying at the university (final year) and I play the Air horn for 5 years. Usually I choose music from the famous films :). I have two sister. I like Cycling, watching movies and Jewelry making. my web blog ... Accupril 10mg prezzo corretto €0.61 �� — Hypertension ([https://simup.it/ simup.it])"

My name's Senaida Purves but everybody calls me Senaida. I'm from Denmark. I'm studying at the university (final year) and I play the Air horn for 5 years. Usually I choose music from the famous films :). I have two sister. I like Cycling, watching movies and Jewelry making. my web blog ... Accupril 10mg prezzo corretto €0.61 �� — Hypertension ([https://simup.it/ simup.it])